- Home
- AUPH vs ESTA Comparison
AUPH vs ESTA Comparison
Compare AUPH & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | ESTA |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AUPH | ESTA |
|---|---|---|
| Price | $16.96 | $69.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $17.25 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 858.1K | 306.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | 42.67 |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $283,055,000.00 | $61,208,000.00 |
| Revenue This Year | $17.54 | $28.05 |
| Revenue Next Year | $15.74 | $26.21 |
| P/E Ratio | $32.00 | ★ N/A |
| Revenue Growth | 20.38 | ★ 76.49 |
| 52 Week Low | $10.34 | $37.37 |
| 52 Week High | $19.25 | $97.59 |
Technical Indicators
Market Signals| Indicator | AUPH | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 61.94 | 38.15 |
| Support Level | $15.65 | $64.11 |
| Resistance Level | $17.80 | $75.75 |
| Average True Range (ATR) | 0.42 | 2.89 |
| MACD | 0.06 | 0.22 |
| Stochastic Oscillator | 85.50 | 30.59 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.